• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    18.92 Dec 19, 4:00PM EST
    |Pre-Market : 18.75 Down 0.17 (0.90%) 9:21AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:18.92
    Open:N/A
    Bid:18.11 x 300
    Ask:18.80 x 2000
    1y Target Est:33.11
    Beta:3.37
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:N/A - N/A
    52wk Range:10.76 - 33.33
    Volume:0
    Avg Vol (3m):2,889,210
    Market Cap:1.70B
    P/E (ttm):N/A
    EPS (ttm):-1.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CLDX 0.00%1.70B
    DNDNN/A
    LLY77.44B
    RHHBY234.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):621.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.32
    Quarterly EPS Est (Dec-14) :-0.35
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback